StimGuard Appoints Tom R. Moore As President

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)--StimGuard LLC, a privately held, commercial stage medical device company, today announced the appointment of Tom R. Moore as president effective immediately. In this role, Moore will provide strategic leadership and assume responsibility for bringing StimGuard’s wirelessly powered microtechnology neurostimulators for the treatment of refractory urgency urinary incontinence as well as overactive bladder syndrome into global commercialization. With more than 18 years of medical device experience, Moore is an ideal candidate to lead the charge for the growth of this revolutionary device, which has the potential to help millions of people who are suffering from incontinence.